GENE THERAPY ANALYTICS: IMPLEMENTING BETTER CMC STRATEGIES (Individual)

Common efficacy and quality challenges impact every company’s ability to effectively produce and manufacture enough viral vector-based gene therapy product to support clinical and commercial supply demands. Our experts share their personal experiences and insight to help anticipate challenges and implement better CMC strategies to accelerate success.

Register for Multiple EBP Events

Network, interact and share ideas with fellow bioprocessing leaders and decision-makers and gain access to applicable ideas on how to improve and accelerate your bioprocess. Access to on-demand event presentations, expert podcasts, event eBooks, and more.